Sandoz is a leader in generic and biosimilar medicines. More than 20,000 people of 100 nationalities work together to ensure 800 million patient treatments are provided by Sandoz. Its portfolio of approximately 1,500 products addresses diseases from the common cold to cancer. Headquartered in Basel, Switzerland, Sandoz traces its heritage back to the year 1886. In 2023, Sandoz recorded sales of USD 9.6 billion.